Biotech

All Articles

Takeda touches brand-new mind of US oncology organization-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our roundup of notable management hirings, shootings as wel...

Vertex, beaten by AATD once again, goes down 2 resources on dispose of pile

.Tip's try to deal with an unusual genetic disease has hit yet another setback. The biotech shook 2 ...

Vir gains 3 T-cell engagers coming from Sanofi, lays off 25% of staff

.Vir Medical's second-quarter profits document wasn't short of huge headlines. The provider accepted...

Galapagos pauses CAR-T tissue treatment hearing over Parkinsonism instance

.Galapagos has stopped registration in a test of a BCMA-directed CAR-T cell therapy, pushing the bra...

James Wilson leaving behind Penn to introduce 2 brand new biotechs

.After much more than three decades, genetics therapy trendsetter James Wilson M.D., Ph.D., is leavi...

3 biotechs attempt to defeat the summer season heat by shedding personnel

.As biotechs attempt to transform a new page in August, at least three firms have actually dropped p...

venBio raises $528M for 5th lifestyle scientific researches VC fund

.Pro equity capital agency venBio has raised yet another half a billion bucks to purchase biotechs d...

Otsuka pays for $800M for Jnana and also its own clinical-stage PKU medicine

.Otsuka Pharmaceutical has picked up Boston-based Jnana Rehabs for $800 million so the Oriental biot...

FibroGen lays off 75% of US personnel as asset flunks 2 more tests

.FibroGen is actually radically restructuring its company, giving up 75% of its own U.S. team and ce...

Tracon unwind weeks after injectable PD-L1 prevention fall short

.Tracon Pharmaceuticals has actually decided to wane procedures weeks after an injectable immune che...